Gerald M. Higa

733 total citations
50 papers, 545 citations indexed

About

Gerald M. Higa is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Gerald M. Higa has authored 50 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Gerald M. Higa's work include HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (11 papers) and Estrogen and related hormone effects (11 papers). Gerald M. Higa is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (11 papers) and Estrogen and related hormone effects (11 papers). Gerald M. Higa collaborates with scholars based in United States, Malaysia and Myanmar. Gerald M. Higa's co-authors include Jame Abraham, Miklos Auber, Walter Murray, Ramin Altaha, Abraham S. Kanate, Michael E. Trigg, E. B. Crowell, Xue Feng, Gerry Hobbs and Xi Tan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Gerald M. Higa

45 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald M. Higa United States 13 238 168 81 68 61 50 545
Elena Strocchi Italy 18 350 1.5× 177 1.1× 82 1.0× 56 0.8× 25 0.4× 52 771
Feyyaz Özdemir Türkiye 13 217 0.9× 118 0.7× 97 1.2× 95 1.4× 44 0.7× 76 587
Ron Vergona United States 13 88 0.4× 138 0.8× 76 0.9× 66 1.0× 54 0.9× 17 734
Mark Wong Australia 14 393 1.7× 123 0.7× 126 1.6× 60 0.9× 25 0.4× 27 658
Girolamo Del Monte Italy 16 365 1.5× 185 1.1× 98 1.2× 49 0.7× 100 1.6× 20 779
Jeanne Fourie United States 11 290 1.2× 204 1.2× 68 0.8× 37 0.5× 21 0.3× 20 589
Silvio Ken Garattini Italy 13 279 1.2× 278 1.7× 180 2.2× 60 0.9× 34 0.6× 42 733
Dirk Trommeshauser Germany 14 284 1.2× 254 1.5× 74 0.9× 78 1.1× 35 0.6× 21 713
Kehua Wu United States 11 210 0.9× 231 1.4× 78 1.0× 49 0.7× 29 0.5× 23 542
Gérard Sanderink France 11 412 1.7× 243 1.4× 102 1.3× 92 1.4× 18 0.3× 17 866

Countries citing papers authored by Gerald M. Higa

Since Specialization
Citations

This map shows the geographic impact of Gerald M. Higa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald M. Higa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald M. Higa more than expected).

Fields of papers citing papers by Gerald M. Higa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald M. Higa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald M. Higa. The network helps show where Gerald M. Higa may publish in the future.

Co-authorship network of co-authors of Gerald M. Higa

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald M. Higa. A scholar is included among the top collaborators of Gerald M. Higa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald M. Higa. Gerald M. Higa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salkeni, Mohamad A., et al.. (2021). Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer. Breast Cancer Targets and Therapy. Volume 13. 539–557. 5 indexed citations
2.
Auber, Miklos, Sijin Wen, Gerald R. Hobbs, & Gerald M. Higa. (2021). Capecitabine as Maintenance Therapy for High-Risk, Resected Colorectal Cancer. PubMed. 8(2). 81–86. 4 indexed citations
3.
Feng, Xue, et al.. (2019). Prevalence and factors associated with potentially inappropriate medication use in older medicare beneficiaries with cancer. Research in Social and Administrative Pharmacy. 16(10). 1459–1471. 6 indexed citations
4.
5.
Higa, Gerald M., Miklos Auber, & Gerry Hobbs. (2012). Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting. Supportive Care in Cancer. 20(11). 2803–2809. 5 indexed citations
6.
Higa, Gerald M.. (2011). Melding breast and prostate cancers alter egos. Expert Review of Endocrinology & Metabolism. 6(3). 301–307.
7.
Hicks, Jason, et al.. (2011). A critical analysis of the (near) legendary status of vitamin D. Expert Review of Endocrinology & Metabolism. 7(1). 103–119. 3 indexed citations
8.
Higa, Gerald M.. (2010). The microtubule as a breast cancer target. Breast Cancer. 18(2). 103–119. 14 indexed citations
9.
Higa, Gerald M., et al.. (2009). Targeting HER2 in breast cancer: overview of long-term experience. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Higa, Gerald M. & Jame Abraham. (2009). Biological mechanisms of bevacizumab-associated adverse events. Expert Review of Anticancer Therapy. 9(7). 999–1007. 44 indexed citations
11.
Higa, Gerald M.. (2009). Breast cancer: beyond the cutting edge. Expert Opinion on Pharmacotherapy. 10(15). 2479–2498. 10 indexed citations
12.
Higa, Gerald M. & Jame Abraham. (2008). Ixabepilone: a new microtubule-targeting agent for breast cancer. Expert Review of Anticancer Therapy. 8(5). 671–681. 4 indexed citations
13.
Higa, Gerald M. & Jame Abraham. (2007). Lapatinib in the treatment of breast cancer. Expert Review of Anticancer Therapy. 7(9). 1183–1192. 101 indexed citations
14.
Roy, Anuja, et al.. (2007). Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer. Expert Opinion on Pharmacotherapy. 8(11). 1675–1691. 2 indexed citations
15.
Higa, Gerald M.. (2004). Signaling multiplex of the epidermal growth factor receptor. Expert Review of Anticancer Therapy. 4(6). 1145–1156. 1 indexed citations
16.
Higa, Gerald M.. (2001). Aromatase inhibitors for breast cancer: pharmacoeconomic considerations. Expert Opinion on Pharmacotherapy. 2(6). 987–995. 2 indexed citations
17.
Higa, Gerald M.. (2000). Altering the Estrogenic Milieu of Breast Cancer with a Focus on the New Aromatase Inhibitors. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(3). 280–291. 1 indexed citations
18.
Higa, Gerald M.. (2000). New Generation Aromatase Inhibitors in Breast Cancer. PharmacoEconomics. 17(2). 121–132. 6 indexed citations
19.
Higa, Gerald M., Mohamadi Sarkar, & Russell F. DeVore. (1999). Pharmacodynamic Profile of Prolonged Etoposide Administration in Patients with Small Cell Lung Cancer and Non‐Hodgkin's Lymphoma. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(1). 101–107. 10 indexed citations
20.
Higa, Gerald M., Russell F. DeVore, Miklos Auber, Joseph P. Lynch, & Kenneth S. Landreth. (1998). Biological and Clinical Correlates after Chemotherapy and Granulocyte Colony‐Stimulating Factor Administration. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(1). 1–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Strocchi Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Ron Vergona Breakdown of academic impact, for papers by Mark Wong Breakdown of academic impact, for papers by Girolamo Del Monte Breakdown of academic impact, for papers by Jeanne Fourie Breakdown of academic impact, for papers by Silvio Ken Garattini Breakdown of academic impact, for papers by Dirk Trommeshauser Breakdown of academic impact, for papers by Kehua Wu Breakdown of academic impact, for papers by Gérard Sanderink
Rankless by CCL
2026